101 related articles for article (PubMed ID: 22701828)
1. Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over 3 months in patients with type 2 diabetes mellitus.
Ved P; Shah S
Indian J Endocrinol Metab; 2012 Mar; 16 Suppl 1(Suppl1):S110-3. PubMed ID: 22701828
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of a Fixed-Dose Combination of Vildagliptin and Pioglitazone in Indian Patients With Type 2 Diabetes Mellitus: A Randomized, Open-Label, Comparative, Phase III Study.
Erande S; Mukhopadhyay J; Dange A; Deogaonkar A; Birla A; Doshi C; Revankar S; B SS; Kumar N; Kadam PV
Cureus; 2023 Sep; 15(9):e44548. PubMed ID: 37795066
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness, safety, and tolerability of vildagliptin or vildagliptin/metformin combination in patients with type 2 diabetes uncontrolled on insulin therapy in a real-world setting in Egypt: The OMEGA study.
El Ebrashy I; El Kafrawy N; Raouf R; Yousry D
Diabetes Res Clin Pract; 2020 Apr; 162():108042. PubMed ID: 32006641
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the Efficacy, Safety, and Tolerability of Combination Therapy of Dapagliflozin and Linagliptin Over Dapagliflozin and Vildagliptin in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.
Dharmalingam M; Kumar Sharma S; Prakash V; Maiti A; Kumar R; Murthy LSS; Ramanathan B; Maheshwari S; Naik Kethavath S; Ogale D; Bachubhai PVK; Sonawane AB; Shah V; Suresh M; Chakraborty S; Kumar Manjunath K
Cureus; 2024 Apr; 16(4):e58115. PubMed ID: 38738005
[TBL] [Abstract][Full Text] [Related]
5. Vildagliptin efficacy in combination with metformin among Jordanian patients with type 2 diabetes mellitus inadequately controlled with metformin.
Al Omari M; Khader Y; Dauod AS; Beni Yonis OA; Khassawneh AH
J Drug Assess; 2016; 5(1):29-33. PubMed ID: 27994943
[No Abstract] [Full Text] [Related]
6. Vildagliptin compared to glimepiride on post-prandial lipemia and on insulin resistance in type 2 diabetic patients.
Derosa G; Bonaventura A; Bianchi L; Romano D; Fogari E; D'Angelo A; Maffioli P
Metabolism; 2014 Jul; 63(7):957-67. PubMed ID: 24874591
[TBL] [Abstract][Full Text] [Related]
7. Real-World Observational Study on Vildagliptin With Insulin (VIL-INS) or Vildagliptin and Metformin With Insulin (VIL-MET-INS) Therapy in Indian Patients With Type 2 Diabetes Mellitus.
Panneerselvam P; Biswas D; Singh H; Dilip Kumar K; Ravi Kumar P; Kalra P; Revankar S; Warrier S
Cureus; 2023 Oct; 15(10):e47190. PubMed ID: 38021574
[TBL] [Abstract][Full Text] [Related]
8. Vildagliptin added to metformin on β-cell function after a euglycemic hyperinsulinemic and hyperglycemic clamp in type 2 diabetes patients.
Derosa G; Ragonesi PD; Carbone A; Fogari E; Bianchi L; Bonaventura A; Romano D; Cicero AF; Maffioli P
Diabetes Technol Ther; 2012 Jun; 14(6):475-84. PubMed ID: 22512264
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of pioglitazone/metformin fixed-dose combination therapy compared with pioglitazone and metformin monotherapy in treating patients with T2DM.
Perez A; Zhao Z; Jacks R; Spanheimer R
Curr Med Res Opin; 2009 Dec; 25(12):2915-23. PubMed ID: 19827910
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of vildagliptin, sitagliptin, and linagliptin as add-on therapy in Chinese patients with T2DM inadequately controlled with dual combination of insulin and traditional oral hypoglycemic agent.
Tang YZ; Wang G; Jiang ZH; Yan TT; Chen YJ; Yang M; Meng LL; Zhu YJ; Li CG; Li Z; Yu P; Ni CL
Diabetol Metab Syndr; 2015; 7():91. PubMed ID: 26500706
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of vildagliptin in clinical practice-results of the PROVIL-study.
Blüher M; Kurz I; Dannenmaier S; Dworak M
World J Diabetes; 2012 Sep; 3(9):161-9. PubMed ID: 23125906
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and Tolerability of Vildagliptin and the Single Pill Combination of Vildagliptin and Metformin in "Real-World" Management of Type 2 Diabetes Mellitus: The G-FORCE Study.
Van Gaal L; Hermans MP; Daci E; Denhaerynck K; De Meester L; MacDonald K; Abraham I; Vancayzeele S; Maris M
Diabetes Ther; 2019 Jun; 10(3):965-979. PubMed ID: 30919316
[TBL] [Abstract][Full Text] [Related]
13. Treatment Compliance with Fixed-Dose Combination of Vildagliptin/Metformin in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin Monotherapy: A 24-Week Observational Study.
Rombopoulos G; Hatzikou M; Athanasiadis A; Elisaf M
Int J Endocrinol; 2015; 2015():251485. PubMed ID: 26089879
[TBL] [Abstract][Full Text] [Related]
14. The effect of vildagliptin relative to sulfonylurea as dual therapy with metformin (or as monotherapy) in Muslim patients with type 2 diabetes fasting during Ramadan in the Middle East: the VIRTUE study.
Hassoun AA; Al-Arouj M; Ibrahim M
Curr Med Res Opin; 2017 Jan; 33(1):161-167. PubMed ID: 27684469
[TBL] [Abstract][Full Text] [Related]
15. Data on vildagliptin and vildagliptin plus metformin combination in type-2 diabetes mellitus management.
Das S; Gupta AK; Bandyopadhyaya B; Darla BH; Arya V; Abhyankar M; Revankar S
Bioinformation; 2021; 17(3):413-423. PubMed ID: 34092962
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of fixed dose combination of acarbose/metformin in Indian Type 2 diabetes patients: Results from observational GLOBE Study.
Saboo B; Reddy GC; Juneja S; Kedia AK; Manjrekar P; Rathod R;
Indian J Endocrinol Metab; 2015; 19(1):129-35. PubMed ID: 25593840
[TBL] [Abstract][Full Text] [Related]
17. Vildagliptin: a review of its use in type 2 diabetes mellitus.
Keating GM
Drugs; 2010 Nov; 70(16):2089-112. PubMed ID: 20964454
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a Combination of Metformin and Vildagliptin in Comparison to Metformin Alone in Type 2 Diabetes Mellitus: A Multicentre, Retrospective, Real-World Evidence Study.
Mohan V; Zargar A; Chawla M; Joshi A; Ayyagari U; Sethi B; Gaurav K; Patted URH; Bhagat SV; Mane AI
Diabetes Metab Syndr Obes; 2021; 14():2925-2933. PubMed ID: 34234490
[TBL] [Abstract][Full Text] [Related]
19. Real-life efficacy and safety of vildagliptin compared with sulfonylureas as add-on to metformin in patients with type 2 diabetes mellitus in Germany.
Göke R; Gruenberger JB; Bader G; Dworak M
Curr Med Res Opin; 2014 May; 30(5):785-9. PubMed ID: 24328429
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of glimepiride/metformin fixed-dose combination vs metformin uptitration in type 2 diabetic patients inadequately controlled on low-dose metformin monotherapy: A randomized, open label, parallel group, multicenter study in Korea.
Kim HS; Kim DM; Cha BS; Park TS; Kim KA; Kim DL; Chung CH; Park JH; Jang HC; Choi DS
J Diabetes Investig; 2014 Nov; 5(6):701-8. PubMed ID: 25422771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
